iiCON at the heart of infectious disease research This year, a new AI robotic laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases was announced in Liverpool UK. The £20 million ($26.4 million) Liverpool Accelerate Laboratory was developed through the Infection Innovation Consortium: iiCON – an initiative dedicated… Read More
Stacey Willard, Vice President of Marketing and Product Management at Nuclera, explores the validation bottleneck for antibody engineering and why generative AI may be the answer to this challenge. Antibody engineering has developed a pronounced asymmetry. AI can now generate and rank antibody candidates at a pace that conventional experimental… Read More
Laboratory automation has been one of the most significant developments in laboratory sciences in recent years, enhancing process quality, eliminating human error and variability, and ultimately making operations more cost-effective and efficient. However, as automation tools become more advanced and complex, this can create connectivity issues and disrupt existing workflows, potentially preventing seamless connection with… Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More
Download this exclusive eBook from Thermo Fisher Scientific to learn more about: The global lab automation market and how it will develop in the next five years The benefits and limitations of automation use How the shift towards intelligent operational ecosystems is advancing drug discovery How scheduling software is enabling… Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More
Read this Whitepaper to understand how Thermo Fisher’s Momentum Workflow Scheduling Software is helping automated labs perform more effectively. You will learn: The current challenges labs face operating automated workflows How workflow scheduling integrates instruments for operational efficiency Why data harmonisation matters Download your copy now. Read More
Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More
The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Angus Sinclair, Chief Scientific Officer at LabGenius Therapeutics. LabGenius is a biotech using AI and robotics to design new cancer therapies, and in vivo efficacy data reveals… Read More
DDW Deputy Editor Diana Turner speaks to the team behind an ambitious project to identify a novel drug target for endometriosis by the end of the year. The Advanced Research & Invention Agency (ARIA), through its AI Scientist programme, has awarded a £500,000 grant to fund a collaboration… Read More
Roche now operates the pharmaceutical industry’s largest announced hybrid-cloud AI factory, totalling more than 3,500 GPUs, following an expansion of its global AI infrastructure. The company has deployed a large-scale AI factory powered by a full stack of the latest-generation NVIDIA accelerated computing and AI, marking the… Read More
This advertorial is sponsored by Revvity. In the modern life science landscape, the journey from a biological hypothesis to a therapeutic breakthrough is rarely a straight line. It is a path frequently obstructed by the physical realities of the bench: the stubborn viscosity of a specific… Read More
